These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8642875

  • 1. Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.
    Palucka AK, Scuderi R, Porwit A, Jeha S, Gruber A, Björkholm M, Beran M, Pisa P.
    Leukemia; 1996 Mar; 10(3):558-63. PubMed ID: 8642875
    [Abstract] [Full Text] [Related]

  • 2. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
    Ishii E, Greaves A, Grunberger T, Freedman MH, Letarte M.
    Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
    [Abstract] [Full Text] [Related]

  • 3. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
    Steenbergen EJ, Verhagen OJ, Nibbering CP, van den Berg H, van Leeuwen EF, Behrendt H, von dem Borne AE, van der Schoot CE.
    Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
    [Abstract] [Full Text] [Related]

  • 4. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Sep; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 5. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
    Gunther R, Chelstrom LM, Finnegan D, Tuel-Ahlgren L, Irvin JD, Myers DE, Uckun FM.
    Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
    [Abstract] [Full Text] [Related]

  • 6. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
    Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M.
    Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
    [Abstract] [Full Text] [Related]

  • 7. Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
    O'Brien S, Jeha S, Kantarjian H, Pisa P, Jin G, Keating M, Beran M.
    Leukemia; 1996 Feb; 10(2):338-44. PubMed ID: 8637244
    [Abstract] [Full Text] [Related]

  • 8. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 Feb; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 9. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D.
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [Abstract] [Full Text] [Related]

  • 10. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
    Cheung AM, Fung TK, Fan AK, Wan TS, Chow HC, Leung JC, Chan LY, Kwong YL, Liang R, Leung AY.
    Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
    [Abstract] [Full Text] [Related]

  • 11. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der Schoot CE.
    Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
    Canale S, Cocco C, Frasson C, Seganfreddo E, Di Carlo E, Ognio E, Sorrentino C, Ribatti D, Zorzoli A, Basso G, Dufour C, Airoldi I.
    Leukemia; 2011 Dec; 25(12):1815-24. PubMed ID: 21701492
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 14. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.
    Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK.
    N Engl J Med; 1993 Oct 28; 329(18):1296-301. PubMed ID: 8413410
    [Abstract] [Full Text] [Related]

  • 15. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM.
    Blood; 1993 Jun 01; 81(11):3052-62. PubMed ID: 8098968
    [Abstract] [Full Text] [Related]

  • 16. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 17. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE.
    Leukemia; 2003 Apr 01; 17(4):760-3. PubMed ID: 12682634
    [Abstract] [Full Text] [Related]

  • 18. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
    Kitchingman GR.
    Leukemia; 1994 Mar 01; 8(3):395-401. PubMed ID: 8127144
    [Abstract] [Full Text] [Related]

  • 19. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 20. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.
    Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.